This triggered unprecedented demand from customers, leading to shortages that impacted sufferers with diabetes who required these medications for his or her Principal indication35, 36. All GLP-1 agonist medications are administered subcutaneously (into your fatty tissue underneath the skin) in one of these spots: The ADA doesn’t recommend a